Phase IV Clinical Trials Brochure

INC Research/inVentiv Health Late Stage leaders help world–class companies bridge the gap from development to commercialization. The key is recognizing that Phase IIIb/IV research is undertaken for different reasons than pre –approval studies. Post–approval success is achieved through documentation and persuasive communication of safety and value, and through an operational approach that reflects the unique characteristics of Late Stage: different goals, different measures, different stakeholders, and different time frames.

At INC Research/inVentiv Health, we strive to ensure our clients’ Late Stage initiatives achieve both scientific and strategic objectives by leveraging our unique perspectives and global resources. The breadth of our experience and services provides us with unique insights into the organizational dynamics that influence a Late Stage initiative, and we are regularly called upon to provide leadership, vision, and training. As a result, our clients achieve consensus and clarity, leading to highly effective research programs that often commence well before product approval. Our clients benefit in achieving both commercial and scientific success through a balanced and operationally cost-efficient approach that recognizes the distinct attributes of the post-approval landscape.

Our services span the spectrum of capabilities to support documentation and demonstration of “real world” safety and value.